LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Затворен

0.32

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.32

Максимум

0.32

Ключови измерители
By Trading Economics
Приходи	605K -15M
Продажби	19M 40M
Марж на печалбата	-37.72
Служители	105
EBITDA	155K -12M

Пазарни показатели
By TradingEconomics
Пазарна капитализация	8.7M 91M
Предишно отваряне	0.32
Предишно затваряне	0.32

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.11.2025 г., 17:45 ч. UTC

Печалби

Значими двигатели на пазара

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14.11.2025 г., 17:31 ч. UTC

Печалби

Значими двигатели на пазара

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

15.11.2025 г., 18:03 ч. UTC

Печалби

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

15.11.2025 г., 15:43 ч. UTC

Печалби

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

15.11.2025 г., 12:00 ч. UTC

Печалби

Meta Opens Pop-Up Stores to Build Buzz for Its AI Glasses -- WSJ

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

15.11.2025 г., 00:08 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

14.11.2025 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14.11.2025 г., 23:02 ч. UTC

Пазарно говорене

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14.11.2025 г., 22:35 ч. UTC

Печалби

Придобивния, сливания и поглъщания

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14.11.2025 г., 22:32 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14.11.2025 г., 22:29 ч. UTC

Печалби

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14.11.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

14.11.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14.11.2025 г., 20:27 ч. UTC

Пазарно говорене

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14.11.2025 г., 20:23 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14.11.2025 г., 20:17 ч. UTC

Придобивния, сливания и поглъщания

Several State Attorneys General Oppose Railroad Merger -- WSJ

14.11.2025 г., 19:29 ч. UTC

Пазарно говорене

Печалби

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14.11.2025 г., 18:44 ч. UTC

Пазарно говорене

Печалби

Disney's Growth Now Hinges More on ESPN -- Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14.11.2025 г., 18:20 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

14.11.2025 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

14.11.2025 г., 16:51 ч. UTC

Пазарно говорене

Starbucks Gets Holiday Sales Lift -- Market Talk

14.11.2025 г., 16:48 ч. UTC

Пазарно говорене

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

14.11.2025 г., 16:38 ч. UTC

Пазарно говорене

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.